Literature DB >> 7533646

A negative regulatory function of B7 revealed in B7-1 transgenic mice.

M P Sethna1, L van Parijs, A H Sharpe, A K Abbas, G J Freeman.   

Abstract

To analyze the functions of T cell costimulators in vivo, we have constructed a transgenic mouse strain that constitutively expresses murine B7-1 on mature B cells. Antibody responses to T-dependent hapten-protein conjugates and serum immunoglobulin levels are markedly depressed in B7-1 transgenic mice. This immune deficiency is not due to an intrinsic B cell defect, as antibody responses to T-independent hapten conjugates are normal. Furthermore, treatment with anti-B7-1 restores the capacity of transgenic mice to respond to hapten-protein conjugates, demonstrating that the deficient antibody responses are directly attributable to the expression of B7-1. These results suggest that the temporally regulated expression of costimulators such as B7-1 may contribute to either initiation or down-regulation (feedback inhibition) of T-dependent immune responses in vivo, and that the inhibitory function is dominant in transgenic mice that constitutively express high levels of this costimulator.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7533646     DOI: 10.1016/1074-7613(94)90072-8

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  15 in total

1.  CD28-independent induction of experimental autoimmune encephalomyelitis.

Authors:  T Chitnis; N Najafian; K A Abdallah; V Dong; H Yagita; M H Sayegh; S J Khoury
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

Review 2.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 3.  Role of B7 signaling in the differentiation of naive CD4+ T cells to effector interleukin-4-producing T helper cells.

Authors:  W C Gause; J F Urban; P Linsley; P Lu
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

4.  Antiviral immune responses in CTLA4 transgenic mice.

Authors:  C Zimmermann; P Seiler; P Lane; R M Zinkernagel
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Aberrant expression of costimulatory molecules in splenocytes of the mevalonate kinase-deficient mouse model of human hyper-IgD syndrome (HIDS).

Authors:  Elizabeth J Hager; Jon D Piganelli; Hubert M Tse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2011-05-24       Impact factor: 4.982

Review 6.  B7-mediated costimulation can either provoke or prevent clinical manifestations of experimental allergic encephalomyelitis.

Authors:  P J Perrin; D Scott; C H June; M K Racke
Journal:  Immunol Res       Date:  1995       Impact factor: 2.829

7.  CD28-mediated costimulation in the absence of phosphatidylinositol 3-kinase association and activation.

Authors:  M E Crooks; D R Littman; R H Carter; D T Fearon; A Weiss; P H Stein
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

8.  Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production.

Authors:  S Nakae; M Asano; R Horai; Y Iwakura
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

9.  Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis.

Authors:  M K Racke; D E Scott; L Quigley; G S Gray; R Abe; C H June; P J Perrin
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 10.  The role of ICOS and other costimulatory molecules in allergy and asthma.

Authors:  Anthony J Coyle; Jose-Carlos Gutierrez-Ramos
Journal:  Springer Semin Immunopathol       Date:  2004-01-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.